Israel Englander Cv Rx, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 323,158 shares of CVRX stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

323,158

Previous 325,389 0.69%

Holding current value

$2.43 Million

Previous $3.98 Million 52.25%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$4.75 - $12.98 $10,597 - $28,958	-2,231 Reduced 0.69%	323,158 $1.9 Million
Q1 2025 May 15, 2025	SELL	$11.05 - $18.4 $879,723 - $1.46 Million	-79,613 Reduced 19.66%	325,389 $3.98 Million
Q4 2024 Feb 14, 2025	SELL	$6.95 - $15.83 $209,667 - $477,559	-30,168 Reduced 6.93%	405,002 $5.13 Million
Q3 2024 Nov 14, 2024	BUY	$7.15 - $12.37 $2.69 Million - $4.65 Million	375,962 Added 634.99%	435,170 $3.83 Million
Q2 2024 Aug 14, 2024	BUY	$6.49 - $19.2 $204,409 - $604,723	31,496 Added 113.65%	59,208 $709,000
Q1 2024 May 15, 2024	SELL	$17.99 - $30.49 $459,032 - $777,982	-25,516 Reduced 47.94%	27,712 $504,000
Q4 2023 Feb 14, 2024	SELL	$11.67 - $33.01 $1.03 Million - $2.91 Million	-88,242 Reduced 62.38%	53,228 $1.67 Million
Q2 2023 Aug 14, 2023	SELL	$8.57 - $15.44 $3.02 Million - $5.44 Million	-352,389 Reduced 71.35%	141,470 $2.18 Million
Q1 2023 May 15, 2023	BUY	$7.08 - $19.4 $1.89 Million - $5.17 Million	266,253 Added 116.98%	493,859 $4.6 Million
Q4 2022 Feb 14, 2023	SELL	$8.94 - $18.35 $1.73 Million - $3.56 Million	-193,944 Reduced 46.01%	227,606 $4.18 Million
Q3 2022 Nov 14, 2022	SELL	$6.12 - $9.5 $343,913 - $533,852	-56,195 Reduced 11.76%	421,550 $3.93 Million

Others Institutions Holding CVRX

# of Institutions

Shares Held

14.9M

Call Options Held

42.2K

Put Options Held

32.4K

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $155M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account